As many as 80,000 British Columbians are infected with hepatitis C, upwards of 70% unaware For the BC Centre for Excellence (BC-CfE) in HIV/AIDS at St. Paul’s, the era of Targeted Disease Elimination is underway. Thanks in large part to work conducted at the BC-CfE, when consistently treated, HIV is now a chronic, manageable disease-not […]
Outreach key to preventing spread of hepatitis C among high risk groups Read More »
BC-CfE Director Dr. Julio Montaner shares his insight on the path forward to addressing the hepatitis C epidemic.
Talking Hep C with Dr. Montaner Read More »
Vancouver’s Downtown Eastside is once again the focus of an expensive project aimed at reducing human suffering and health care costs caused by injection drug use. Health Minister Terry Lake on Thursday announced a $5-million study that will look at how to reduce the spread of hepatitis C among intravenous drug users, sex workers and
B.C. to spend $5 million to help reduce spread of hepatitis C Read More »
FROM THE LANCET INFECTIOUS DISEASES Iatrogenic factors, not high-risk behaviors, were the main cause of the exponential spread of hepatitis C virus infections in North America, according to a phylogenetic study published online in the Lancet Infectious Diseases. The study shifted the epicenter of spread back by more than 15 years, to about 1950, when
Hepatitis C virus transmission peaked in 1950 Read More »
Common belief is that risky behaviour is what spread hepatitis C among baby boomers (born between 1945 and 1964), but a new study indicates that is not necessarily so. If results are correct, there could be “a tsunami” of cases of this serious liver disease coming, says Dr. Julio Montaner, co-investigator and director of the
Routine medical procedures may have spread hep C Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
